United States· US:73590-0028_a21d7c1c-801d-0f92-e053-2995a90a9781
THE SKIN HOUSE Vital BrightSerum
A medicinal product containing niacinamide, registered in United States by NOKSIBCHO cosmetic Co., Ltd..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- NIACINAMIDE
- Manufacturer
- NOKSIBCHO cosmetic Co., Ltd.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1173590-0028-1
- ndc11735900028130 mL in 1 BOTTLE (73590-0028-1)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Niacinamide in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United Kingdom250-B3 capsulesTriOn Pharma Ltd
- NorwayNAD+ Cell RegeneratorLife Extension
- FranceNICOBION 500 mg, comprimé pelliculéTEOFARMA
- BelgiumBecozymeBayer
- PolandVitaminum PP 200 mgPolfarmex S.A.
- Japanニコチン酸アミドＮＩＳＳＨＡゾンネボード製薬
- IrelandNicam 4% w/w GelDermal Laboratories (Ireland) Limited
- GermanyNicotinamid AxicurAxicorp Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Belgium · Nicotinamide Sterop
- Germany · Nicotinamid Axicur
- France · Nicobion, Nicotinamide Renaudin
- United Kingdom (Northern Ireland) · Freederm, Freederm Treatment
- Ireland · Nicam
- Italy · Nicotinamide Idi
- Poland · Vitaminum Pp Polfarmex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e7b163a2-bb66-4ff1-84b3-67a58b4ac00f GET /v1/drugs/e7b163a2-bb66-4ff1-84b3-67a58b4ac00f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "2",
"substance": "NIACINAMIDE",
"productndc": "73590-0028",
"dosage_form": "LIQUID",
"dea_schedule": null,
"strength_unit": "g/100mL",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG OTHER"
}See everything about niacinamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.